Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Adverse events from compounded semaglutide have led to hundreds of hospitalizations, highlighting critical safety concerns for healthcare providers managing patients seeking weight loss solutions.
Endocrinology, Diabetes, Metabolism November 20th 2024
Journal of Neurology, Neurosurgery & Psychiatry
CGRP inhibitors have shown promise in reducing migraine days and improving quality of life, but their wide-ranging effects throughout the body warrant careful consideration and long-term monitoring.
Clinical Pharmacology August 27th 2024
Semaglutide medications, while effective for weight loss, may carry unexpected mental health risks that require careful monitoring and consideration in clinical practice.
Endocrinology, Diabetes, Metabolism August 13th 2024
Medical Professionals Reference (MPR)
Collecting patient allergy information is futile if it’s not integrated into the prescribing process. This case demonstrates the legal and patient safety risks of inadequate medication safety systems.
All Specialties July 17th 2024
Rapid weight loss from semaglutide use can lead to breast ptosis, mirroring effects seen after bariatric surgery. Healthcare providers should be prepared to counsel patients on this potential outcome and offer strategies for management.
Endocrinology, Diabetes, Metabolism July 17th 2024
GoodRx for Healthcare Professionals
Several medications, including antihistamines, muscle relaxers, and benzodiazepines, are known to cause fatigue. Understanding these effects and managing patient expectations can help mitigate this common side effect.
All Specialties June 4th 2024